Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer

被引：0
|
作者：
Hakon Blomstrand
Ursula Scheibling
Charlotte Bratthäll
Henrik Green
Nils O. Elander
机构：
[1] Ryhov County Hospital,Department of Oncology
[2] Linköping University,Division of Oncology, Department of clinical and experimental medicine, Faculty of medicine and health sciences
[3] Kalmar County Hospital,Department of Oncology
[4] Linköping University,Division of Drug Research, Department of Medical Health Sciences
[5] Department of Forensic Genetics and Forensic Toxicology,undefined
[6] National Board of Forensic Medicine,undefined
来源：
BMC Cancer | / 19卷
关键词：
Pancreatic cancer; Chemotherapy; Gemcitabine; Nab-paclitaxel; Bone marrow toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
    Blomstrand, Hakon
    Scheibling, Ursula
    Bratthall, Charlotte
    Green, Henrik
    Elander, Nils O.
    BMC CANCER, 2019, 19 (1)
  • [2] A modified regimen of nab-paclitaxel and gemcitabine in advanced pancreatic cancer
    Osman, M. A. M.
    McDermott, R.
    Fennelly, D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [3] A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers
    Wang, Ying
    Camateros, Pierre
    Cheung, Winson Y.
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (01) : 62 - 68
  • [4] Phase I study of nab-paclitaxel and gemcitabine combination in patients with advanced pancreatic cancer
    Drengler, R. L.
    Smith, L. S.
    Wood, T. E.
    Borad, M. J.
    Ramanathan, R. K.
    Laheru, D. A.
    Hidalgo, M.
    Von Hoff, D. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers
    Ying Wang
    Pierre Camateros
    Winson Y. Cheung
    Journal of Gastrointestinal Cancer, 2019, 50 : 62 - 68
  • [6] Dose intensity of nab-paclitaxel and gemcitabine chemotherapy in metastatic pancreatic cancer
    Lim, Alexander
    Kim, Dae Won
    Kim, Kunhwa
    Kim, Richard D.
    Bottiglieri, Salvatore Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [7] EFFICACY AND SAFETY OF NAB-PACLITAXEL IN COMBINATION WITH GEMCITABINE FOR METASTATIC PANCREATIC CANCER
    You, Min Su
    Ryu, Ji Kon
    Kang, Jinwoo
    Choi, Jin Ho
    Choi, Young Hoon
    Huh, Gunn
    Paik, Woo Hyun
    Lee, Sang Hyub
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2018, 154 (06) : S285 - S285
  • [8] Gemcitabine and nab-paclitaxel combination therapy for the treatment of metastatic pancreatic cancer
    Sasaki, Takashi
    Kanata, Ryo
    Saito, Kei
    Yamada, Ikuhiro
    Matsuyama, Masato
    Ozaka, Masato
    Takano, Kouichi
    Sasahira, Naoki
    ANNALS OF ONCOLOGY, 2016, 27
  • [9] The retrospective analysis of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer
    Ueno, M.
    Kobayashi, S.
    Ohkawa, S.
    Tezuka, S.
    Moriya, S.
    Morimoto, M.
    ANNALS OF ONCOLOGY, 2015, 26 : 67 - 67
  • [10] Offlabel nab-paclitaxel: Gemcitabine chemotherapy in advanced pancreatic cancer-A monoinstitutional experience.
    Lo Re, Giovanni
    Santeufemia, Davide Adriano
    Ius, Antonino
    Del Conte, Alessandro
    Foltran, Luisa
    Fadda, Giovanni Maria
    Basso, Stefano Maria
    Marus, Wally
    Chiara, Giordano Bruno
    Stuto, Angelo
    Tosolini, Giancarlo
    Sulfaro, Sandro
    Spaziante, Roberto
    Nicolosi, Gianluigi
    Boz, Gianni
    Mancinelli, Paolo
    Tumolo, Salvatore
    Bidoll, Ettore
    Cozzi, Cinzia
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345